Nprx Should You Buy the Bombardier Inc. Rally
These days after a highly eventful 2020, many聽TSX stocks are trading at premium valuations. Investors have been forward looking towards a recovery, resulting in several stocks trading at prices that are higher than even before the pandemic.While some of these valuations are warranted, other stocks are undoubtedly overvalued. And w stanley cup ith uncertainty still at heightened levels, there is a significant amount of risk.In addition to these high-valuation stanley becher stocks having increased risk in a market crash, there s also not much upside left, even if the reopening of the economy does go smoothly.So, investors have had to look elsewhere for growth, with several tu stanley canada rning to high-risk growth stocks that have been subject to major speculation. These are also stocks you want to avoid.Instead, investors need to focus on long-term investing.聽It going to be a lot more difficult to find high-quality, long-term TSX stocks with attractive valuations in 2021. However, they are out there.Here are two of the Xjmh Buy These 4 TSX Metals Stocks With Massive Upside
Clearwater Seafoods Inc. TS stanley mug X:CLR and High Liner F water bottle stanley oods Inc. TSX:HLF have both recently reported quarterly earnings. Although the news was not as good as expected for shareholders of High Liner, shareholders of Clearwater made out much worse after being dealt a hand of bad shrimp. Shares declined by 15% on the news of a pullback in earnings, while shares of High Liner were down only 2% for the day.As these two companies are competing firms, investors have a unique opportunity to bet on the best horse or hedge their bet by buying shares in one company and selling/shor stanley cups uk ting shares of the other. This is known as a long/short strategy. For investors seeking the better name to buy, we must first carefully consider each company independently.For the third quarter of the year, sales at Clearwater moved sideways at $611 million as gross margins fell from $161 million 26.3% of revenues for Q3 2016 to $109 million 17.9% of revenues for Q3 2017 . EBITDA followed suit, declining from 17.5% of
